Cargando…

South African healthcare workers’ knowledge of dolutegravir's drug–drug interactions in the first year of its rollout: a cross‐sectional online survey

INTRODUCTION: In December 2019, dolutegravir‐based treatment was recommended as first‐line antiretroviral therapy (ART) in South Africa. Dolutegravir has clinically significant interactions with several commonly used drugs, such as rifampicin, metformin and cation‐containing medicines. National guid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chisholm, Briony S., Swart, Annoesjka M., Blockman, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901146/ https://www.ncbi.nlm.nih.gov/pubmed/35255196 http://dx.doi.org/10.1002/jia2.25885

Ejemplares similares

The impact of the National HIV Health Care Worker Hotline on patient care in South Africa
por: Chisholm, Briony S, et al.
Publicado: (2011)

Cases of antiretroviral-associated gynaecomastia reported to the National HIV & Tuberculosis Health Care Worker Hotline in South Africa
por: Njuguna, Christine, et al.
Publicado: (2016)

HIV, drugs and the kidney
por: Wearne, Nicola, et al.
Publicado: (2020)

Understanding and Responding to Prescribing Patterns of Sodium Valproate-Containing Medicines in Pregnant Women and Women of Childbearing Age in Western Cape, South Africa
por: Mehta, Ushma, et al.
Publicado: (2020)

The knowledge and attitudes of South African-based runners regarding the use of analgesics during training and competition
por: Thorpe, R, et al.
Publicado: (2022)

Rollout of dolutegravir-based antiretroviral therapy in sub-Saharan Africa and its public health implications
por: Wilson, Herieth Ismael, et al.
Publicado: (2020)

Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance
por: Wolf, Eva, et al.
Publicado: (2021)

COVID-19 vaccination rollout in the World Health Organization African region: status at end June 2022 and way forward
por: Impouma, Benido, et al.
Publicado: (2022)

Self-reported health behaviors and risk perceptions following the COVID-19 vaccination rollout in the USA: an online survey study
por: Thorpe, A., et al.
Publicado: (2022)

Engendering health systems in response to national rollout of dolutegravir-based regimens among women of childbearing potential: a qualitative study with stakeholders in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2020)

Point-of-Care Viral Load Testing to Manage HIV Viremia During the Rollout of Dolutegravir-Based ART in South Africa: A Randomized Feasibility Study (POwER)
por: Dorward, Jienchi, et al.
Publicado: (2023)

Household Knowledge of Antimicrobials and Antimicrobial Resistance in the Wake of an Accredited Drug Dispensing Outlet (ADDO) Program Rollout in Tanzania
por: Simba, Daudi, et al.
Publicado: (2016)

Influenza Vaccination Uptake and Hesitancy among Healthcare Workers in Early 2021 at the Start of the COVID-19 Vaccine Rollout in Cape Town, South Africa
por: Alobwede, Samuel M., et al.
Publicado: (2022)

COVID Vaccine Rollout for Older Adults in South Korea
por: Park, Chan Mi
Publicado: (2021)

Vaccine rollout strategies: The case for vaccinating essential workers early
por: Mulberry, Nicola, et al.
Publicado: (2021)

Knowledge, attitudes and practices of South African healthcare workers regarding the prevention and treatment of influenza among HIV-infected individuals
por: Duque, Jazmin, et al.
Publicado: (2017)

Effect of Rifabutin in Dolutegravir Dosing: A Case Series
por: Mendoza, Maria A., et al.
Publicado: (2022)

The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific
por: Rainima-Qaniuci, Merelesita, et al.
Publicado: (2022)

COVID-19 Vaccination Rollout: Aspects of Acceptability in South Africa
por: Steenberg, Bent, et al.
Publicado: (2022)

COVID-19 Vaccination Rollout: Aspects of Hesitancy in South Africa
por: Steenberg, Bent, et al.
Publicado: (2023)

Will drug resistance against dolutegravir in initial therapy ever occur?
por: Wainberg, Mark A., et al.
Publicado: (2015)

Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine
por: Walimbwa, Stephen I., et al.
Publicado: (2019)

Real-World Experience with Dolutegravir-Based Two-Drug Regimens
por: Ward, Douglas, et al.
Publicado: (2020)

Knowledge, attitude, and practice regarding COVID-19 among healthcare workers in Henan, China
por: Zhang, M., et al.
Publicado: (2020)

Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV
por: Chapola, John C., et al.
Publicado: (2023)

Stable HIV‐1 reservoirs on dolutegravir maintenance monotherapy: the MONODO study
por: Sculier, D, et al.
Publicado: (2018)

Impact of Obesity on the Drug–Drug Interaction Between Dolutegravir and Rifampicin or Any Other Strong Inducers
por: Berton, Mattia, et al.
Publicado: (2023)

Is Resistance to Dolutegravir Possible When This Drug Is Used in First-Line Therapy?
por: Mesplède, Thibault, et al.
Publicado: (2014)

Weight gain during the dolutegravir transition in the African Cohort Study
por: Esber, Allahna L., et al.
Publicado: (2022)

The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout
por: Zaqout, Ahmed, et al.
Publicado: (2021)

Low Prevalence of Pre-Treatment and Acquired Drug Resistance to Dolutegravir among Treatment Naïve Individuals Initiating on Tenofovir, Lamivudine and Dolutegravir in Zimbabwe
por: Kouamou, Vinie, et al.
Publicado: (2023)

Determinants of Confidence in Overall Knowledge About COVID-19 Among Healthcare Workers in South Africa: Results From an Online Survey
por: Manyaapelo, Thabang, et al.
Publicado: (2021)

Knowledge, attitudes and perceptions of a patient population on the COVID-19 vaccine rollout
por: Purasram, Makaira, et al.
Publicado: (2022)

Drug use in pregnancy: Knowledge of drug dispensers and pregnant women in Dar es Salaam, Tanzania
por: Kamuhabwa, Appolinary, et al.
Publicado: (2011)

EOS 5 client rollout
por: Reis, Manuel
Publicado: (2023)

In vitro activity of dolutegravir against wild-type and integrase inhibitor-resistant HIV-2
por: Smith, Robert A, et al.
Publicado: (2015)

Predictors of virological failure in HIV‐1‐infected patients switching to dolutegravir maintenance monotherapy
por: Wijting, IEA, et al.
Publicado: (2018)

Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life Settings
por: Cattaneo, Dario, et al.
Publicado: (2020)

2485. Real-world Experience with Dolutegravir Plus Rilpivirine Two-Drug Regimen
por: Ward, Douglas, et al.
Publicado: (2019)

Isotopic Radiolabeling of the Antiretroviral Drug [(18)F]Dolutegravir for Pharmacokinetic PET Imaging
por: Tisseraud, Marion, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j0qer221eg2cdf9h3l15g63996